Li N - Search Results

1

Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance.

Li N, Mao W, Gao Y, Wang D, Song Z, Chen Z. Li N, et al. J Pharm Biomed Anal. 2021 Aug 5;202:114147. doi: 10.1016/j.jpba.2021.114147. Epub 2021 May 18. J Pharm Biomed Anal. 2021. PMID: 34029974

2

Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma.

Cheng L, Li N, Xu XL, Mao WM. Cheng L, et al. Among authors: li n. Curr Drug Targets. 2020;21(15):1606-1612. doi: 10.2174/1389450121666200719011234. Curr Drug Targets. 2020. PMID: 32682370 Review.

3

Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.

Chen Z, Dai Y, Huang X, Chen K, Gao Y, Li N, Wang D, Chen A, Yang Q, Hong Y, Zeng S, Mao W. Chen Z, et al. Among authors: li n. Front Oncol. 2020 Aug 26;10:1545. doi: 10.3389/fonc.2020.01545. eCollection 2020. Front Oncol. 2020. PMID: 32984013 Free PMC article.

4

Clinical Relevance of PD-L1 Expression and CD8+ T Cells' Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma.

Xu X, Li N, Wang D, Chen W, Fan Y. Xu X, et al. Among authors: li n. Front Oncol. 2021 Jun 24;11:683432. doi: 10.3389/fonc.2021.683432. eCollection 2021. Front Oncol. 2021. PMID: 34249733 Free PMC article.

5

Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma.

Li N, Yang C, Zhou S, Song S, Jin Y, Wang D, Liu J, Gao Y, Yang H, Mao W, Chen Z. Li N, et al. Diagnostics (Basel). 2021 Jul 16;11(7):1281. doi: 10.3390/diagnostics11071281. Diagnostics (Basel). 2021. PMID: 34359365 Free PMC article.

6

The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.

Xu X, Wang D, Li N, Sheng J, Xie M, Zhou Z, Cheng G, Fan Y. Xu X, et al. Among authors: li n. Ann Surg Oncol. 2022 May;29(5):2930-2940. doi: 10.1245/s10434-021-10928-9. Epub 2021 Nov 9. Ann Surg Oncol. 2022. PMID: 34751872

7

[No title available]

[No authors listed] [No authors listed] PMID: 34839423

8

Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.

Chen Z, Song S, Yang C, Dai Z, Gao Y, Li N, Zhu J, Mao W, Liu J. Chen Z, et al. Among authors: li n. Clin Chim Acta. 2022 Jan 1;524:34-42. doi: 10.1016/j.cca.2021.11.024. Epub 2021 Nov 27. Clin Chim Acta. 2022. PMID: 34843704

9

A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Xu X, Wang D, Chen W, Li N, Suwinski R, Rossi A, Rosell R, Zhong J, Fan Y. Xu X, et al. Among authors: li n. Transl Lung Cancer Res. 2021 Dec;10(12):4511-4525. doi: 10.21037/tlcr-21-899. Transl Lung Cancer Res. 2021. PMID: 35070757 Free PMC article.

10

ASO Author Reflection: The TME-Related Gene AIF1 Signature Predicts Esophageal Carcinoma Prognosis.

Xu X, Wang D, Li N, Sheng J, Xie M, Zhou Z, Cheng G, Fan Y. Xu X, et al. Among authors: li n. Ann Surg Oncol. 2022 May;29(5):2941. doi: 10.1245/s10434-021-10955-6. Epub 2022 Feb 15. Ann Surg Oncol. 2022. PMID: 35169974 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,428 results

Search Page

Filters